Physician profile
Johnny Tam
NPI 1508949934
$1,204.98
in general payments reported to CMS, 2019-2025
8 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.18 · 2022: $167 · 2023: $255 · 2024: $567 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $473.40 | 2023-2025 | Miebo, Vyzulta, Xiidra |
| Alcon Vision LLC | $278.16 | 2023-2024 | Rocklatan, Simbrinza, Rhopressa |
| Johnson & Johnson Vision Care, INC. | $190.82 | 2022-2024 | |
| Glaukos Corporation | $73.61 | 2024 | Photrexa |
| Smith+Nephew, INC. | $69.09 | 2025 | Pico 7 |
| Solventum Corporation | $63.16 | 2024 | Prevena |
| Molnlycke Health Care US, LLC | $34.56 | 2022 | |
| Janssen Pharmaceuticals, INC | $22.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Tam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.